Abstract 2037: Engineering multiplexed NRF2 reporters to decipher single cell oscillations in real time.

Abstract Tumor cell survival after therapy and the emergence of recurrent disease are major contributors to breast cancer mortality. NRF2, a master regulator of antioxidant and metabolic stress responses, is frequently activated in therapy-resistant and recurrent tumor cells, yet its regulation in the absence of canonical Nfe2l2/Keap1 mutations remains poorly understood. To enable real-time visualization of NRF2 dynamics, we developed a dual fluorescent reporter system to independently monitor NRF2 protein stability and transcriptional activity at single-cell resolution. The first reporter (Neh2-YFP) fuses YFP to the NRF2 Neh2 degron domain, providing a readout of KEAP1-dependent NRF2 protein turnover. The second reporter (ARE-CFP) places CFP under control of antioxidant response elements (AREs), enabling measurement of NRF2-dependent transcriptional output. Using confocal live-cell imaging in NMuMG mammary epithelial cells, we validated both reporters by demonstrating increased fluorescence after exposure to NRF2 activators (H2O2, TBHQ) and decreased signal with NRF2 inhibitors (ML385, luteolin). Building on this foundation, we will use the reporters to define how NRF2 activity fluctuates over short timescales and how these dynamics change during transitions from therapy-naïve to drug-tolerant, recurrent, or metastatic cell states. Because the two reporters disentangle protein stabilization from transcriptional competence, this system will also allow us to identify noncanonical mechanisms of NRF2 activation - such as altered kinase signaling or autophagy - specifically in breast cancer models lacking Nfe2l2/Keap1 mutations. Together, this dual-reporter platform enables dynamic, single-cell characterization of NRF2 regulation and will provide new insight into how NRF2-driven stress tolerance and metabolic adaptation contribute to tumor persistence, recurrence, and metastatic progression. Citation Format: Naurisha Kapoor, Yasemin Ceyhan Ozdemir, James V. Alvarez. Engineering multiplexed NRF2 reporters to decipher single cell oscillations in real time [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 2037.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2026-04-03
DOI
https://doi.org/10.1158/1538-7445.am2026-2037
Primary Topic
Protein Degradation and Inhibitors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 2037: Engineering multiplexed NRF2 reporters to decipher single cell oscillations in real time.

James V. Alvarez, Naurisha Kapoor
Cancer Research
Protein Degradation and Inhibitors
article

Abstract 2037: Engineering multiplexed NRF2 reporters to decipher single cell oscillations in real time.

James V. Alvarez, Naurisha Kapoor
article en

Abstract

Abstract Tumor cell survival after therapy and the emergence of recurrent disease are major contributors to breast cancer mortality. NRF2, a master regulator of antioxidant and metabolic stress responses, is frequently activated in therapy-resistant and recurrent tumor cells, yet its regulation in the absence of canonical Nfe2l2/Keap1 mutations remains poorly understood. To enable real-time visualization of NRF2 dynamics, we developed a dual fluorescent reporter system to independently monitor NRF2 protein stability and transcriptional activity at single-cell resolution. The first reporter (Neh2-YFP) fuses YFP to the NRF2 Neh2 degron domain, providing a readout of KEAP1-dependent NRF2 protein turnover. The second reporter (ARE-CFP) places CFP under control of antioxidant response elements (AREs), enabling measurement of NRF2-dependent transcriptional output. Using confocal live-cell imaging in NMuMG mammary epithelial cells, we validated both reporters by demonstrating increased fluorescence after exposure to NRF2 activators (H2O2, TBHQ) and decreased signal with NRF2 inhibitors (ML385, luteolin). Building on this foundation, we will use the reporters to define how NRF2 activity fluctuates over short timescales and how these dynamics change during transitions from therapy-naïve to drug-tolerant, recurrent, or metastatic cell states. Because the two reporters disentangle protein stabilization from transcriptional competence, this system will also allow us to identify noncanonical mechanisms of NRF2 activation - such as altered kinase signaling or autophagy - specifically in breast cancer models lacking Nfe2l2/Keap1 mutations. Together, this dual-reporter platform enables dynamic, single-cell characterization of NRF2 regulation and will provide new insight into how NRF2-driven stress tolerance and metabolic adaptation contribute to tumor persistence, recurrence, and metastatic progression. Citation Format: Naurisha Kapoor, Yasemin Ceyhan Ozdemir, James V. Alvarez. Engineering multiplexed NRF2 reporters to decipher single cell oscillations in real time [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 2037.

Cancer ResearchVol. 86(7_Supplement)
University of Washington (US), Fred Hutch Cancer Center (US)
Good health and well-being
Openalex Percentile: Top 22%
Protein Degradation and Inhibitors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.